0000899243-17-029733.txt : 20171229 0000899243-17-029733.hdr.sgml : 20171229 20171229172637 ACCESSION NUMBER: 0000899243-17-029733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171227 FILED AS OF DATE: 20171229 DATE AS OF CHANGE: 20171229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADELMAN DANIEL C MD CENTRAL INDEX KEY: 0001222037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 171282748 MAIL ADDRESS: STREET 1: 23 WOODLEAF AVENUE CITY: REDWOOD CITY STATE: CA ZIP: 94061 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001631650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452748244 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 BUSINESS PHONE: (650) 614-5220 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 FORMER COMPANY: FORMER CONFORMED NAME: Allergen Research Corp DATE OF NAME CHANGE: 20150123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-27 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001222037 ADELMAN DANIEL C MD AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 0 1 0 0 Chief Medical Officer Common Stock, $0.0001 par value 2017-12-27 4 M 0 3283 11.45 A 3283 D Common Stock, $0.0001 par value 2017-12-27 4 S 0 3283 40.00 D 0 D Stock Option(right to buy) 11.45 2017-12-27 4 M 0 3283 0.00 D 2026-06-24 Common Stock 3283 226717 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 16, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date /s/ Douglas T. Sheehy, as Attorney in Fact for Daniel C. Adelman 2017-12-29